Found 13 matching trials
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
NAExperimental data suggest that transplantation of endothelial progenitor ce...
Location
Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University
3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects
PHASE1This study investigates safety and efficacy of traumatic bone defects treat...
Location
LIMITED LIABILITY COMPANY "A.A. PARTNERS" (Medical company ilayaยฎ)
Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis
PHASE1Endothelial Progenitor Cells (EPC) represent a small cellular population of...
Location
Clinica Universidad de Navarra
Pulmonary Hypertension: Assessment of Cell Therapy
PHASE1The primary objective is to establish the safety of autologous progenitor c...
Location
St. Michael's Hospital
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
NAExperimental data suggest that transplantation of endothelial progenitor ce...
Location
Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
PHASE1The purpose of this study is to evaluate the feasibility, efficacy, and saf...
Location
Zhujiang Hospital, Southern Medical University
Cell Therapy for Coronary Heart Disease
PHASE2Impaired contractile function after a heart attack and due to coronary hear...
Location
J. W. Goethe University Hospitals
Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot
NAThe vascular pathologic basis of diabetic foot include arterial obstruction...
Location
Shanghai Tenth people's hospital, Tongji university
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension
PHASE2The SAPPHIRE clinical trial seeks to establish the efficacy and safety of r...
Location
Peter Lougheed Center, University of Calgary
The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial
PHASE2This will be the first clinical trial to include a strategy designed to enh...
Status
Active Not Recruiting
Location
University of Ottawa Heart Institute